Synapse - Mark Kris

Search Within

Mark Kris

Results (73)

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers

Journal Article

Sabari, J. K.; Leonardi, G. C.; Shu, C. A.; Umeton, R.; Montecalvo, J.; Ni, A.; Chen, R.; Dienstag, J.; Mrad, C.; Bergagnini, I.; more...
Annals of Oncology (2018)

Fulltext@MSK | Save

YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics

Journal Article

Fan, P. D.; Narzisi, G.; Jayaprakash, A. D.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Yu, H. A.; Jordan, E. J.; Paik, P. K.; more...
Proceedings of the National Academy of Sciences of the United States of America (2018)

Fulltext@MSK | Save

Concurrent alterations in EGFR-mutant lung cancers associated with resistance to EGFR kinase inhibitors and characterization of MTOR as a mediator of resistance

Journal Article

Yu, H. A.; Suzawa, K.; Jordan, E.; Zehir, A.; Ni, A.; Kim, R.; Kris, M. G.; Hellmann, M. D.; Li, B. T.; Somwar, R.; more...
Clinical Cancer Research (2018)

Fulltext@MSK | Save

Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers

Journal Article

Drilon, A.; Somwar, R.; Mangatt, B. P.; Edgren, H.; Desmeules, P.; Ruusulehto, A.; Smith, R. S.; Delasos, L.; Vojnic, M.; Plodkowski, A. J.; more...
Cancer Discovery (2018)

Fulltext@MSK | Save

Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing

Journal Article

Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer

Journal Article

Arbour, K. C.; Jordan, E.; Kim, H. R.; Dienstag, J.; Yu, H. A.; Sanchez-Vega, F.; Lito, P.; Berger, M.; Solit, D. B.; Hellmann, M.; more...
Clinical Cancer Research (2018)

Fulltext@MSK | Save

YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing

Meeting Abstract

Fan, P. D.; Narzisi, G.; Jayaprakash, A.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Jordan, E.; Wang, L.; Jungbluth, A. A.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

A phase 2 study of cabozantinib for patients with advanced RET-rearranged lung cancers

Meeting Abstract

Drilon, A.; Somwar, R.; Smith, R.; Delasos, L.; Albano, M.; Van Voorthuyson, M.; Wang, L.; Rekhtman, N.; Ni, A.; Plodkowski, A.; more...
Journal of Thoracic Oncology (2017)

Fulltext@MSK | Save

Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy

Journal Article

Inoue-Yamauchi, A.; Jeng, P. S.; Kim, K.; Chen, H. C.; Han, S.; Ganesan, Y. T.; Ishizawa, K.; Jebiwott, S.; Dong, Y.; Pietanza, M. C.; more...
Nature Communications (2017)

Fulltext@MSK | Save

Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies

Journal Article

Jordan, E. J.; Kim, H. R.; Arcila, M. E.; Barron, D.; Chakravarty, D.; Gao, J. J.; Chang, M. T.; Ni, A.; Kundra, R.; Jonsson, P.; more...
Cancer Discovery (2017)

Fulltext@MSK | Save